What is the recommended age group for using Tessalon (benzonatate) as a cough suppressant?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tessalon (Benzonatate) Age Recommendations

Tessalon (benzonatate) is FDA-approved only for children over 10 years of age and adults, and should never be used in children under 10 due to documented fatal overdoses in this age group. 1

FDA-Approved Age Range

  • Approved for children over 10 years of age and adults at a usual dose of one 100 mg or 200 mg capsule three times daily as needed for cough 1
  • Maximum daily dose is 600 mg in three divided doses 1
  • Safety and effectiveness in children below age 10 have NOT been established 1

Critical Safety Concerns in Young Children

Accidental ingestion in children under 10 years old has resulted in death, with fatal outcomes occurring within 15-20 minutes to one hour of ingestion 1, 2:

  • Five fatalities occurred in children 2 years of age and younger from accidental ingestions 2
  • Emergency department data captured 12 overdose cases from accidental ingestions in children aged 1-3 years 2
  • Signs of overdose include seizures, cardiac arrest, coma, brain edema, apnea, and respiratory arrest—often within 15 minutes 1, 2

Pediatric Exposure Trends

Recent surveillance data (2010-2018) reveals concerning patterns 3:

  • Among 4,689 pediatric benzonatate exposure cases, 77% were unintentional exposures 3
  • 83% of unintentional exposures involved children 0-5 years old 3
  • Rising patterns of both unintentional ingestion in young children and intentional ingestion in adolescents 10-16 years old 3

Clinical Context for Cough Management

Benzonatate should not be first-line therapy even in approved age groups, as current pediatric cough guidelines emphasize treating underlying causes rather than symptomatic suppression 4, 5:

  • Over-the-counter cough medications (including antitussives) are not recommended for children under 6 years due to lack of efficacy and safety concerns 4, 5
  • For chronic cough in children ≤14 years, treatment should target the underlying etiology rather than using empiric antitussive therapy 4, 5

Essential Safety Warnings

Capsules must be swallowed whole—never broken, chewed, dissolved, cut, or crushed 1:

  • Release of benzonatate in the mouth produces temporary local anesthesia of oral mucosa and can cause choking 1
  • If numbness or tingling of tongue, mouth, throat, or face occurs, refrain from oral intake until numbness resolves 1

Keep out of reach of children at all times 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cough and Congestion Management in Infants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.